Literature DB >> 23175134

Nanotoxicity assessment of quantum dots: from cellular to primate studies.

Ken-Tye Yong1, Wing-Cheung Law, Rui Hu, Ling Ye, Liwei Liu, Mark T Swihart, Paras N Prasad.   

Abstract

Tremendous research efforts have been devoted to fabricating high quality quantum dots (QDs) for applications in biology and medicine. Much of this research was pursued with an ultimate goal of using QDs in clinical applications. However, a great deal of concern has been voiced about the potential hazards of QDs due to their heavy-metal content. Many studies have demonstrated toxicity of various QDs in cell culture studies. However, in a smaller number of studies using small animal models (mice and rats), no abnormal behaviour or tissue damage was noticed over periods of months after the systemic administration of QDs. Nevertheless, the correlation of these results with the potential for negative effects of QD on humans remains unclear. Many urgent questions must be answered before the QDs community moves into the clinical research phase. This review provides an overview of the toxicity assessment of QDs, ranging from cell culture studies to animal models and discusses their findings. Guidelines for using various nonhuman primate models for QD toxicity studies are highlighted. This review article is intended to promote the awareness of current developments of QD applications in biology, the potential toxicity of QDs, and approaches to minimizing toxicity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23175134     DOI: 10.1039/c2cs35392j

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  60 in total

1.  Sensing with photoluminescent semiconductor quantum dots.

Authors:  Margaret Chern; Joshua C Kays; Shashi Bhuckory; Allison M Dennis
Journal:  Methods Appl Fluoresc       Date:  2019-01-24       Impact factor: 3.009

2.  Fundamentals of Optical Imaging.

Authors:  Liyun Lin; Pengfei Jiang; Zhouzhou Bao; Wen Pang; Shihui Ding; Ming-Jie Yin; Pengcheng Li; Bobo Gu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Facilitating Translational Nanomedicine via Predictive Safety Assessment.

Authors:  Vahid Mirshafiee; Wen Jiang; Bingbing Sun; Xiang Wang; Tian Xia
Journal:  Mol Ther       Date:  2017-04-13       Impact factor: 11.454

4.  Gated Luminescence Imaging of Silicon Nanoparticles.

Authors:  Jinmyoung Joo; Xiangyou Liu; Venkata Ramana Kotamraju; Erkki Ruoslahti; Yoonkey Nam; Michael J Sailor
Journal:  ACS Nano       Date:  2015-06-09       Impact factor: 15.881

5.  Bioimaging: illuminating the deep.

Authors:  Kyryl Zagorovsky; Warren C W Chan
Journal:  Nat Mater       Date:  2013-04       Impact factor: 43.841

6.  Cytotoxicity investigation of luminescent nanohybrids based on chitosan and carboxymethyl chitosan conjugated with Bi2S3 quantum dots for biomedical applications.

Authors:  Sandhra M Carvalho; Herman S Mansur; Fábio P Ramanery; Alexandra A P Mansur; Zelia I P Lobato; Maria F Leite
Journal:  Toxicol Res (Camb)       Date:  2016-04-14       Impact factor: 3.524

7.  Meta-analysis of cellular toxicity for cadmium-containing quantum dots.

Authors:  Eunkeu Oh; Rong Liu; Andre Nel; Kelly Boeneman Gemill; Muhammad Bilal; Yoram Cohen; Igor L Medintz
Journal:  Nat Nanotechnol       Date:  2016-02-29       Impact factor: 39.213

8.  Polymeric Nanoparticles Controlled by On-Chip Self-Assembly Enhance Cancer Treatment Effectiveness.

Authors:  Sungjin Jung; Junseok Lee; Junha Lim; Jeeyeon Suh; Taeyoung Kim; Jungho Ahn; Won Jong Kim; YongTae Kim
Journal:  Adv Healthc Mater       Date:  2020-10-18       Impact factor: 9.933

9.  Evolution and Clinical Translation of Drug Delivery Nanomaterials.

Authors:  Shabir Hassan; Gyan Prakash; Aycabal Ozturk; Saghi Saghazadeh; Mohammad Farhan Sohail; Jungmok Seo; Mehmet Dockmeci; Yu Shrike Zhang; Ali Khademhosseini
Journal:  Nano Today       Date:  2017-08-02       Impact factor: 20.722

Review 10.  Nanotechnologies for noninvasive measurement of drug release.

Authors:  Thomas Moore; Hongyu Chen; Rachel Morrison; Fenglin Wang; Jeffrey N Anker; Frank Alexis
Journal:  Mol Pharm       Date:  2013-11-26       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.